Acute pancreatitis (AP) is the leading gastrointestinalrelated discharge diagnosis in the United States [1] . Th e clinical outcome of AP varies broadly with mortality rates reaching 30% in severe cases [2] . An accurate and early prediction of disease severity would be benefi cial in directing the patient to the most appropriate management, and ultimately in improving outcome. Although multiple clinical scoring systems have been developed, they show modest accuracy in predicting persistent organ failure in AP [3, 4] . Among the available clinical scoring systems Systemic Infl ammatory Response Syndrome (SIRS) and Bedside Index for Severity in AP (BISAP) scores have been extensively studied in recent years and are easily applicable in daily practice [3] [4] [5] . Computed tomography (CT) is the imaging modality of choice for the diagnosis of AP and for the assessment of local complications [2, 6] . In the past 30 years, several radiological scoring systems have been proposed to predict severity of AP [7] . Among the most commonly used scoring systems is CT Severity Index (CTSI), based on the assessment of pancreatic/peri-pancreatic infl ammation and fl uid collections, and on the presence and extent of pancreatic necrosis [8] . In 2004, Mortele et al introduced the "modifi ed CTSI" (mCTSI) scoring system which combines the evaluation of pancreatic and peri-pancreatic infl ammatory fi ndings with extra-pancreatic complications [9] . Few other scoring systems rely only on extra-pancreatic fi ndings [10] [11] [12] [13] . Among them, the ExtraPancreatic Infl ammation on CT (EPIC) score, introduced by de Waele et al in 2007, is based on presence and extent of pleural eff usion, ascites, and retroperitoneal /mesenteric infl ammation [12] . Th ere has been limited validation of the prognostic role of the imaging scoring systems based only on extra-pancreatic fi ndings.
In the current issue of the Annals of Gastroenterology, Sharma et al compared two CT scoring systems relying only on extra-pancreatic fi ndings (i.e. EPIC score and renal rim sign) with clinical (i.e. BISAP and SIRS) and conventional CT scores (CTSI and mCTSI) for prediction of persistent organ failure, need for pancreatic drainage/debridement, and mortality [14] .
Th e study was conducted retrospectively in a cohort of 105 patients with AP who underwent contrast-enhanced CT 3-10 days aft er onset of symptoms. Th e authors showed comparable predictive accuracy of these scoring systems, although the BISAP score had the highest performance in predicting persistent organ failure and mortality. In this study, the CTbased scores did not provide any additional prognostic value to the clinically-based score. In a recent, large prospective study, Bollen et al found no statistically signifi cant diff erence in predicting severity of AP between CT-based and clinical scoring systems obtained within 24 h of hospitalization [15] .
Th e available literature does not show any additional value of CT for assessment of patient prognosis in the early phase of AP. At this point the question for a researcher interested in identifying predictive imaging biomarkers of AP is: Should we stop looking for such biomarkers?
We believe that the answer is no and that more work can be done. Extra-pancreatic imaging fi ndings, although included in multiple CT-based scoring systems, have been assessed in qualitative or semi-quantitative way. Research on full quantifi cation of these fi ndings has been scant. In their recent study Meyrignac et al showed signifi cant correlation between volumetric measurement of extra-pancreatic necrosis and clinical outcome [16] . We believe that a full quantifi cation of infl ammatory imaging fi ndings of AP could provide new insights into the predictive role of CT. Th e required imaging analysis can be facilitated by the utilization of dedicated soft ware. In addition, the terminology introduced with the revised Atlanta classifi cation allows uniform standardization of the fi ndings to be analyzed, such as peri-pancreatic necrosis and fl uid collections [2] .
CT images off er a vast amount of data perhaps as yet not used to its full extent in patients with AP. More work can be done -let's not give up.
